Dataset Information


VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.

ABSTRACT: Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor ?B activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.


PROVIDER: S-EPMC6154478 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7206010 | BioStudies
1000-01-01 | S-EPMC5481740 | BioStudies
2017-01-01 | S-EPMC5350518 | BioStudies
1000-01-01 | S-EPMC4246264 | BioStudies
2012-01-01 | S-EPMC3331999 | BioStudies
1000-01-01 | S-EPMC5725450 | BioStudies
2013-01-01 | S-EPMC3540187 | BioStudies
1000-01-01 | S-EPMC5820357 | BioStudies
1000-01-01 | S-EPMC4204774 | BioStudies
2011-01-01 | S-EPMC3192834 | BioStudies